ARCHIVES

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Has Congressional Mandate Fr Planning Clinical Trials of Unconventional Therapies, Chabner Says

June 5, 1992

The Varmus Era: Controversy Continues

January 6, 1995

Consensus Conference Planned On Adjuvant Chemotherapy For Breast Cancer

March 22, 1985

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014

Consensus Conference Recommends Adjuvant Chemotherapy In Breast Cancer Only For Premenopausal Women

July 25, 1980